8-KEarnings & ResultsExhibits & Filings

DANAHER CORP /DE/ 8-K Report, Financial Results (Jan 12, 2016)

Filed January 12, 2016For Securities:DHR

Summary

Danaher Corporation (DHR) filed an 8-K on January 11, 2016, to provide updates on its anticipated financial performance for the fourth quarter of 2015. This filing precedes a presentation at the J.P. Morgan Healthcare Conference scheduled for January 12, 2016. The report includes a press release and a presentation furnished as exhibits, offering insights into the company's expected financial results for the close of 2015. Investors should review these materials for preliminary information on Danaher's operational and financial condition as it entered 2016. While the 8-K itself does not contain detailed financial figures, it serves as a crucial announcement mechanism for the information that will be discussed at the upcoming conference. The accompanying press release and presentation are incorporated by reference, indicating their importance for understanding Danaher's performance outlook. Investors interested in the company's recent financial trajectory and future expectations should pay close attention to the details provided in these furnished documents.

Key Highlights

  • 1Danaher Corporation filed an 8-K on January 11, 2016, with the SEC.
  • 2The filing relates to anticipated financial performance for the fourth quarter of 2015.
  • 3The information was provided in advance of the J.P. Morgan Healthcare Conference on January 12, 2016.
  • 4The 8-K includes a press release and a presentation furnished as exhibits.
  • 5These materials offer insights into Danaher's expected financial performance for Q4 2015.
  • 6The information is furnished under Item 2.02 (Results of Operations and Financial Condition).
  • 7The filing serves to inform investors ahead of a key industry conference.

Frequently Asked Questions

The main purpose of this 8-K filing is to inform investors about Danaher Corporation's anticipated financial performance for the fourth quarter of 2015, in advance of their presentation at the J.P. Morgan Healthcare Conference.

The detailed financial information is expected to be found in the press release (Exhibit 99.1) and the presentation for the J. P. Morgan Healthcare Conference (Exhibit 99.2), which are furnished as exhibits to this 8-K filing and incorporated by reference.

No, this 8-K filing contains anticipated financial performance and outlook. The detailed and audited financial results would typically be found in a subsequent Form 10-Q or 10-K filing.

The J.P. Morgan Healthcare Conference is a major event where companies present their strategic direction and financial outlook to investors, analysts, and the broader healthcare industry. Danaher's participation and the information shared there are important indicators of the company's performance and future prospects.